Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor γ (PPARγ) and PPARγcoactivator-1 (PGC1)

Public Health Nutrition - Tập 10 Số 10A - Trang 1132-1137 - 2007
Gema Medina‐Gómez1, Sarah L. Gray1, Antonio Vidal–Puig1
1Department of Clinical Biochemistry and Medicine, University of Cambridge, Box 232, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 2QR, UK

Tóm tắt

AbstractObesity is characterised by an increase in the adipose deposits, resulting from an imbalance between food intake and energy expenditure. When expansion of the adipose tissue reaches its maximum limit, as in obesity, fat accumulates in non-adipose tissues such as liver, heart, muscle and pancreas, developing a toxic response known as lipotoxicity, a condition that promotes the development of insulin resistance and other metabolic complications. Thus, the lipotoxic state may contribute to the increased risk of insulin resistance, diabetes, fatty liver and cardiovascular complications associated with obesity.We are interested in studying adipose tissue, specifically how mechanisms of adipogenesis and remodelling of adipose tissue, in terms of size and function of the adipocytes, could be considered a strategy to increase the capacity for lipid storage and prevent lipotoxicity. The peroxisome proliferator-activated receptors (PPARs) are a family of transcription factors that regulate energy balance by promoting either energy deposition or energy dissipation. Under normal physiological conditions, PPARγ is mainly expressed in adipose tissue and regulates diverse functions such as the development of fat cells and their capacity to store lipids. The generation of PPARγ knockout mice, either tissue specific or isoform specific, has provided new models to study PPARγ’s role in adipose tissue differentiation and function and have highlighted the essential role of PPARγ in adipogenesis and lipogenesis.A second strategy to prevent lipotoxicity is to increase the capacity of tissues to oxidise fatty acids. PPARγcoactivator-1α is a coactivator of PPARγ that induces the expression of genes that promote the differentiation of preadipocytes to brown adipocytes. Recently, it has been implicated in increasing the oxidation of fatty acids via increasing mitochondrial capacity and function, making this co-factor a key candidate for the treatment of lipotoxicity.

Từ khóa


Tài liệu tham khảo

10.1016/j.biochi.2004.11.014

10.1074/jbc.C100631200

10.1074/jbc.M103241200

10.1038/43185

10.1016/S0092-8674(00)81410-5

10.1111/j.1462-8902.2004.00356.x

10.1002/dmrr.249

10.1038/35093050

Sugiyama, 2000, [Mechanisms of thiazolidinedione derivatives for hypoglycemic and insulin sensitizing effects], Nippon Rinsho, 58, 370

10.1038/sj.ijo.0802859

10.1074/jbc.M303643200

10.1073/pnas.061035098

10.1073/pnas.2336090100

10.1210/endo-100-4-1169

10.1016/j.it.2003.10.013

10.1056/NEJM199909163411204

10.1016/S1097-2765(00)80211-7

10.1038/35053000

10.1172/JCI118703

10.1074/jbc.272.32.20230

10.1038/sj.ijo.0802854

10.1146/annurev.cellbio.16.1.145

10.1038/372425a0

10.1074/jbc.C200251200

10.1073/pnas.2536828100

10.1016/S1097-2765(00)80209-9

10.1210/endo.142.10.8458

10.1055/s-2001-18581

10.1074/jbc.M305235200

10.1172/JCI8538

10.1007/s001250051560

10.1038/nature00904

10.2337/diab.38.8.991

Shimomura, 1999, Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy, Nature, 401, 73, 10.1038/43448

10.1073/pnas.0403652101

10.2337/diab.44.8.863

10.1152/ajpendo.00312.2002

10.1210/en.2003-0580

10.2337/diabetes.53.6.1621

10.1073/pnas.0730870100

10.1038/35093131

10.2337/diabetes.54.6.1706

10.1126/science.1126010

10.1101/gad.953802

10.2337/diabetes.51.1.37

10.1172/JCI119424

10.1210/en.2003-0870

Fruhbeck, 2001, The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation, American Journal of Physiology Endocrinology and Metabolism, 280, E827, 10.1152/ajpendo.2001.280.6.E827

10.1038/90911

10.1016/S1388-1981(02)00342-6

10.2337/diabetes.51.1.7

10.2337/diabetes.47.4.507

10.1152/ajpendo.00591.2005

10.1042/bj20030200

10.1172/JCI10583

10.1073/pnas.95.16.9558

10.1172/JCI25102

Thông tin
Thông tin xuất bản

Public Health Nutrition

Tập 10 Số 10A

1132-1137

Thông tin tác giả